Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|February 17, 2024
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarizationWenxin Xu, Jialei Weng, Minghao Xu, et al.Cellular Reprogramming|May 12, 2023
Functions of Key Enzymes of Glycolytic Metabolism in Tumor MicroenvironmentWenxin Xu, Jialei Weng, Minghao Xu, et al.Frontiers in Cell and Developmental Biology|September 19, 2025
The mechanosensitive protein ANTXR1 is involved in maintaining cartilage homeostasis in post-traumatic osteoarthritisZhuangzhuang Miao, Junjie Liu, Pengfei Cheng, et al.Frontiers in Psychology|March 25, 2026
The neuro-immuno-metabolic axis of exercise: a unified mechanistic framework for exercise-induced cognitive enhancement and psychological resilienceYinghao Shen, Zhujun Mao, Yupeng Yang, et al.Annals of Translational Medicine|April 12, 2021
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patientsQiang Zhou, Chenhao Zhou, Yirui Yin, et al.Journal of Experimental & Clinical Cancer Research : CR|August 19, 2022
Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathwayMinghao Xu, Chenhao Zhou, Jialei Weng, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 17, 2017
Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular CarcinomaYinghao Shen, Chenhao Zhou, Guodong Zhu, et al.Journal for Immunotherapy of Cancer|June 29, 2023
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinomaJialei Weng, Shaoqing Liu, Qiang Zhou, et al.Cell Reports. Medicine|July 1, 2025
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinomaMinghao Xu, Yimin Zheng, Junbo Chen, et al.Journal for Immunotherapy of Cancer|May 2, 2025
FMO2<sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinomaWenxin Xu, Jialei Weng, Yufei Zhao, et al.Pageof 3